AI Article Synopsis
- Uterus transplantation (UTx) is a new procedure allowing women with uterine factor infertility to have biological children, with the process ending in a planned hysterectomy post-delivery.
- Immunosuppressive therapy is crucial for UTx, requiring a careful balance to protect both the mother and the baby, with current practices largely drawn from solid organ transplantation.
- Recent clinical trials have provided valuable insights into immunosuppression efficacy, improving maintenance treatment and responses to rejection, while future advancements may enhance understanding of UTx biology.
Article Abstract
Purpose Of Review: Clinical uterus transplantation (UTx) is growing rapidly. The procedure represents the only therapy for women with absolute uterine factor infertility to give birth to a biological baby. Immunosuppression after UTx needs to carefully balance effects with the healthy mother and baby. Unique for UTx is the 'temporary' character of the procedure with a transplant hysterectomy being performed after delivery. Most of the practice on immunosuppression in UTx is currently based on the experience in solid organ transplantation (SOT).
Recent Findings: Clinical UTx-trials have been performed in centers worldwide during the recent years and experience on immunosuppression has accumulated.
Summary: Immunosuppression in UTx has been successfully applied as maintenance treatment in addition to effectively treating acute T- and B-cell mediated rejections. Understanding the biology of UTx in more detail is expected to refine future approaches.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MOT.0000000000000925 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Unique Lessons From the Natural Progression of Rejection in Human Uterine Allografts.
Clin Transplant
August 2024
Division of Abdominal Transplantation, Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, Texas, USA.
Introduction: Uterus transplantation (UTx) is a novel treatment for absolute uterine infertility. Acute T cell-mediated rejection (TCMR) can be monitored only through serial cervical biopsies.
Methods: This study, the first of its kind in human transplantation, evaluated clinical, serological, and pathophysiological manifestations of allograft rejection from immunosuppression withdrawal (ISW) to graft hysterectomy (Hx).
Cutting Edge: Hypoxia Sensing by the Histone Demethylase UTX (KDM6A) Limits Colitogenic CD4+ T Cells in Mucosal Inflammation.
J Immunol
April 2024
Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA.
Hypoxia is a hallmark of inflammatory conditions (e.g., inflammatory bowel disease [IBD]), and adaptive responses have consequently evolved to protect against hypoxia-associated tissue injury.
View Article and Find Full Text PDFLiving-Donor Uterus Transplantation: A Clinical Review.
J Clin Med
January 2024
Vascular Surgery and Organ Transplant Unit, University Hospital of Catania, 95123 Catania, Italy.
Uterus transplantation (UTx) is currently the only available treatment for absolute uterine factor infertility. More than 90 uterus transplantations have been performed worldwide, mostly from living donors. Living-donor (LD) UTx is a challenging surgical procedure since it poses ethical issues, and it is a high-risk and invasive surgery with higher hysterectomy-related risks compared to conventional hysterectomy.
View Article and Find Full Text PDFDevelopmental transcriptomic patterns can be altered by transgenic overexpression of Uty.
Sci Rep
November 2023
Center for Epigenetic Research in Child Health and Brain Development, University of Maryland School of Medicine, Baltimore, USA.
The genetic material encoded on X and Y chromosomes provides the foundation by which biological sex differences are established. Epigenetic regulators expressed on these sex chromosomes, including Kdm6a (Utx), Kdm5c, and Ddx3x have far-reaching impacts on transcriptional control of phenotypic sex differences. Although the functionality of UTY (Kdm6c, the Y-linked homologue of UTX), has been supported by more recent studies, its role in developmental sex differences is not understood.
View Article and Find Full Text PDFMiracles of science: Birth after uterus transplantation.
J Obstet Gynaecol Res
January 2024
Department of Plastic and Reconstructive Surgery, Akdeniz University Faculty of Medicine, Antalya, Turkey.
Aim: The concept of regaining childbearing ability via uterus transplantation (UTx) motivates many infertile women to pursue giving birth to their own children. This article provides insight into maternal and neonatal outcomes of the procedure globally and facilitates quality of care in related medical fields.
Methods: The authors searched ISI Web of Science, MEDLINE, non-PubMed-indexed journals, and common search engines to identify peer-review publications and unpublished sources in scientific reference databases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!